Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...
O]ur companies have until June of 2028 to get there. That should not be a sigh of relief. That should be a, oh my gosh, we've ...
The plan raises a number of questions, including how the payments will be distributed across large teams of staffers.
Contract work opportunities have grown year over year, and recent reports show more people are in this type of role, according to BioSpace data. Three biopharma professionals share why they’ve become ...
The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.
Our food system isn’t built to adapt to volatility — it’s built to defend the status quo, even as fragility grows, says Gould ...
Cosmos Health Inc. ('Cosmos Health' or the 'Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its ...
Biotech hot picks spotlight Xenon, United Therapeutics and Axsome as Phase III data and FDA decisions approach.
Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...
As an original manufacturer, Cloud-Clone redefines lab efficiency with high-sensitivity multiplex kits, offering a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results